Skandinaviska Enskilda Banken (SEB)
PFE icon

Skandinaviska Enskilda Banken (SEB)’s Pfizer PFE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,237,677
Closed -$30.8M – 554
2025
Q4 		$30.8M Buy
1,237,677
+131,472
+12% +$3.32M 0.12% 140
2025
Q3 		$28.2M Sell
1,106,205
-85,974
-7% -$2.12M 0.11% 148
2025
Q2 		$28.9M Buy
1,192,179
+19,880
+2% +$464K 0.13% 137
2025
Q1 		$29.7M Buy
1,172,299
+33,762
+3% +$883K 0.15% 127
2024
Q4 		$30.1M Sell
1,138,537
-10,467
-0.9% -$284K 0.14% 130
2024
Q3 		$33.3M Buy
1,149,004
+9,199
+0.8% +$268K 0.15% 122
2024
Q2 		$31.9M Sell
1,139,805
-192,601
-14% -$5.3M 0.15% 112
2024
Q1 		$37M Sell
1,332,406
-108,500
-8% -$3.01M 0.18% 99
2023
Q4 		$41.4M Sell
1,440,906
-236,614
-14% -$7.15M 0.24% 79
2023
Q3 		$55.6M Buy
1,677,520
+47,998
+3% +$1.7M 0.37% 54
2023
Q2 		$59.8M Sell
1,629,522
-1,899,381
-54% -$73.9M 0.39% 53
2023
Q1 		$144M Sell
3,528,903
-647,925
-16% -$28M 1.01% 16
2022
Q4 		$214M Sell
4,176,828
-354,790
-8% -$17M 1.61% 6
2022
Q3 		$198M Sell
4,531,618
-746,473
-14% -$36.3M 1.53% 7
2022
Q2 		$277M Sell
5,278,091
-116,840
-2% -$5.95M 2.04% 4
2022
Q1 		$280M Buy
5,394,931
+682,717
+14% +$35.4M 1.64% 7
2021
Q4 		$275M Buy
4,712,214
+1,110,707
+31% +$55M 1.42% 9
2021
Q3 		$155M Buy
3,601,507
+870,956
+32% +$38.6M 0.85% 18
2021
Q2 		$107M Sell
2,730,551
-28,811
-1% -$1.12M 0.66% 24
2021
Q1 		$100M Sell
2,759,362
-527,211
-16% -$18.7M 0.66% 28
2020
Q4 		$121M Buy
3,286,573
+308,570
+10% +$11.3M 0.83% 19
2020
Q3 		$104M Buy
2,978,003
+125,059
+4% +$4.38M 0.76% 23
2020
Q2 		$88.5M Buy
2,852,944
+4,686
+0.2% +$159K 0.72% 32
2020
Q1 		$88.2M Buy
2,848,258
+338,980
+14% +$11.6M 0.89% 24
2019
Q4 		$93.3M Buy
2,509,278
+854,083
+52% +$30.4M 0.73% 33
2019
Q3 		$56.4M Sell
1,655,195
-128,867
-7% -$4.69M 0.48% 52
2019
Q2 		$73.3M Sell
1,784,062
-869,057
-33% -$34.5M 0.63% 34
2019
Q1 		$107M Sell
2,653,119
-5,820,740
-69% -$233M 0.98% 23
2018
Q4 		$351M Sell
8,473,859
-478,567
-5% -$19.9M 3.14% 1
2018
Q3 		$374M Buy
8,952,426
+1,772,326
+25% +$68.2M 2.84% 1
2018
Q2 		$247M Buy
7,180,100
+688,633
+11% +$23.5M 2.11% 6
2018
Q1 		$219M Buy
6,491,467
+4,321,128
+199% +$149M 2.11% 9
2017
Q4 		$74.6M Buy
2,170,339
+500,868
+30% +$17.1M 0.64% 41
2017
Q3 		$56.5M Buy
1,669,471
+93,441
+6% +$3M 0.51% 49
2017
Q2 		$50.2M Sell
1,576,030
-875,897
-36% -$27.6M 0.48% 52
2017
Q1 		$79.6M Sell
2,451,927
-866,571
-26% -$27.3M 0.8% 29
2016
Q4 		$102M Sell
3,318,498
-25,277
-0.8% -$772K 1.23% 23
2016
Q3 		$107M Sell
3,343,775
-193,697
-5% -$6.48M 1.16% 21
2016
Q2 		$118M Buy
3,537,472
+801,009
+29% +$25.6M 1.32% 22
2016
Q1 		$76.3M Sell
2,736,463
-1,669,231
-38% -$47.7M 0.86% 27
2015
Q4 		$135M Buy
+4,405,694
New +$139M 1.75% 14

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s PFE Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,237,677 shares — an estimated $30.8M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PFE in Q4 2015 and held it in 41 quarters. The position peaked at $374M in Q3 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 1,237,677 Pfizer shares in Q1 2026, an estimated $30.8M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Pfizer in Q4 2015 and held it in 41 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Pfizer position peaked at $374M in Q3 2018.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.